Skip to content

Monthly Novel FDA Drug Approvals - PharmaKB Report - January 2023

The Pharmaceutical KnowledgeBase (PharmaKB.com) provides research and financial intelligence about companies and their approved drugs as well as drug candidates in clinical trials. In this monthly PharmaKB report, we provide an update about four novel drugs approved by the US FDA in January of this year.  By referencing new drugs as “novel” the FDA is confirming that the medicine being approved contains ingredients and/or a mechanism of action that the FDA hasn’t previously approved. 

January 2023 – Novel FDA Drug Approvals

The US FDA approved four novel drugs in January 2023:

Lecanemab

Bexagliflozin

 

Pirtobrutinib

Elacestrant